Stéphane Ducassou

2.6k total citations
80 papers, 1.1k citations indexed

About

Stéphane Ducassou is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Stéphane Ducassou has authored 80 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pediatrics, Perinatology and Child Health, 36 papers in Public Health, Environmental and Occupational Health and 22 papers in Hematology. Recurrent topics in Stéphane Ducassou's work include Acute Lymphoblastic Leukemia research (36 papers), Childhood Cancer Survivors' Quality of Life (33 papers) and Acute Myeloid Leukemia Research (12 papers). Stéphane Ducassou is often cited by papers focused on Acute Lymphoblastic Leukemia research (36 papers), Childhood Cancer Survivors' Quality of Life (33 papers) and Acute Myeloid Leukemia Research (12 papers). Stéphane Ducassou collaborates with scholars based in France, Netherlands and United States. Stéphane Ducassou's co-authors include André Baruchel, Guy Leverger, Laurent Orsi, Jacqueline Clavel, Yves Bertrand, Brigitte Nelken, Virginie Gandemer, Nicolas Sirvent, Denis Hémon and Jérémie Rudant and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Stéphane Ducassou

75 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphane Ducassou France 20 431 422 242 227 197 80 1.1k
Danièle Sommelet France 16 345 0.8× 361 0.9× 150 0.6× 149 0.7× 164 0.8× 28 820
Alain Robert France 24 352 0.8× 518 1.2× 401 1.7× 257 1.1× 281 1.4× 45 1.4k
Asim Belgaumi Saudi Arabia 18 244 0.6× 293 0.7× 151 0.6× 305 1.3× 248 1.3× 63 959
Thuan Chong Quah Singapore 15 452 1.0× 474 1.1× 171 0.7× 193 0.9× 162 0.8× 56 874
Goda Vaitkevičienė Lithuania 18 751 1.7× 892 2.1× 300 1.2× 203 0.9× 148 0.8× 51 1.2k
Roberto Rivera‐Luna Mexico 16 280 0.6× 326 0.8× 141 0.6× 176 0.8× 129 0.7× 67 808
Pamela J. Goodman United States 12 433 1.0× 403 1.0× 85 0.4× 154 0.7× 144 0.7× 22 995
Jón Kristinsson Netherlands 14 263 0.6× 400 0.9× 304 1.3× 98 0.4× 157 0.8× 23 905
Ólafur Gísli Jónsson Iceland 15 427 1.0× 543 1.3× 250 1.0× 167 0.7× 133 0.7× 39 798
Ólafur G. Jónsson Denmark 26 569 1.3× 967 2.3× 1.2k 4.9× 326 1.4× 262 1.3× 65 2.0k

Countries citing papers authored by Stéphane Ducassou

Since Specialization
Citations

This map shows the geographic impact of Stéphane Ducassou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Ducassou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Ducassou more than expected).

Fields of papers citing papers by Stéphane Ducassou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Ducassou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Ducassou. The network helps show where Stéphane Ducassou may publish in the future.

Co-authorship network of co-authors of Stéphane Ducassou

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Ducassou. A scholar is included among the top collaborators of Stéphane Ducassou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Ducassou. Stéphane Ducassou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Aladjidi, Nathalie, Audrey Contet, Jean‐Hugues Dalle, et al.. (2024). Outcome of childhood ALK‐positive anaplastic large cell lymphoma relapses: Real‐life experience of the French Society of Pediatric Oncology (SFCE) cohort of 75 French children. Pediatric Blood & Cancer. 72(1). e31397–e31397. 1 indexed citations
4.
Corradini, Nadège, Nicolás André, Estelle Thébaud, et al.. (2024). Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS. European Journal of Cancer. 201. 113923–113923. 1 indexed citations
5.
Geoerger, Birgit, Manuel Schiff, Virginie Penard‐Lacronique, et al.. (2023). Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation. Nature Medicine. 29(6). 1358–1363. 5 indexed citations
6.
Hijiya, Nobuko, Alexey Maschan, Carmelo Rizzari, et al.. (2023). The long-term efficacy and safety of nilotinib in pediatric patients with CML: a 5-year update of the DIALOG study. Blood Advances. 7(23). 7279–7289. 4 indexed citations
7.
Saultier, Paul, Gérard Michel, Anne Sîrvent, et al.. (2023). Chronic Graft-Versus-Host Disease in Long-Term Survivors of Childhood Leukemia. Blood. 142(Supplement 1). 3762–3762. 1 indexed citations
8.
Dourthe, Marie-Émilie, Anne Aupérin, Jacques Bosq, et al.. (2022). Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study. Haematologica. 107(9). 2173–2182. 12 indexed citations
9.
Hijiya, Nobuko, Alexey Maschan, Carmelo Rizzari, et al.. (2021). A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety. Blood Advances. 5(14). 2925–2934. 19 indexed citations
10.
Ducassou, Stéphane, Helder Fernandes, Hélène Savel, et al.. (2020). Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation. The Journal of Pediatrics. 231. 223–230. 1 indexed citations
11.
Ducassou, Stéphane, Helder Fernandes, G Leverger, et al.. (2020). Second‐line treatment trends and long‐term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years. British Journal of Haematology. 189(5). 931–942. 13 indexed citations
12.
Hijiya, Nobuko, Alexey Maschan, Carmelo Rizzari, et al.. (2019). Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia. Blood. 134(23). 2036–2045. 37 indexed citations
13.
Bouty, Aurore, E. Dobremez, Luke Harper, et al.. (2018). Bladder Dysfunction in Children with Neurofibromatosis Type I: Report of Four Cases and Review of the Literature. Urologia Internationalis. 100(3). 339–345. 5 indexed citations
14.
Bailey, Helen D., Brigitte Lacour, Dominique Valteau‐Couanet, et al.. (2017). Maternal use of household pesticides during pregnancy and risk of neuroblastoma in offspring. A pooled analysis of the ESTELLE and ESCALE French studies (SFCE). Cancer Causes & Control. 28(10). 1125–1132. 14 indexed citations
15.
Oudin, Claire, Pascal Auquier, Audrey Contet, et al.. (2015). Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study. Bone Marrow Transplantation. 50(11). 1438–1444. 37 indexed citations
16.
Ducassou, Stéphane, Anne Auvrignon, Cécile Verite, et al.. (2015). Invasive Fungal Infections in Pediatric Acute Myelogenous Leukemia. The Pediatric Infectious Disease Journal. 34(11). 1262–1264. 10 indexed citations
17.
Berger, Claire, et al.. (2015). Objectifs et organisation de la surveillance à long terme après un cancer dans l’enfance. Bulletin du Cancer. 102(7-8). 579–585. 16 indexed citations
18.
Ajrouche, Roula, Jérémie Rudant, Laurent Orsi, et al.. (2014). Maternal reproductive history, fertility treatments and folic acid supplementation in the risk of childhood acute leukemia: the ESTELLE Study. Cancer Causes & Control. 25(10). 1283–1293. 37 indexed citations
19.
Trioche, Pascale, Brigitte Nelken, Gérard Michel, et al.. (2012). French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia. Experimental Hematology and Oncology. 1(1). 39–39. 8 indexed citations
20.
Ducassou, Stéphane, Céline Ferlay, Christophe Bergeron, et al.. (2011). Clinical presentation, evolution, and prognosis of precursor B‐cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951. British Journal of Haematology. 152(4). 441–451. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danièle Sommelet Breakdown of academic impact, for papers by Alain Robert Breakdown of academic impact, for papers by Asim Belgaumi Breakdown of academic impact, for papers by Thuan Chong Quah Breakdown of academic impact, for papers by Goda Vaitkevičienė Breakdown of academic impact, for papers by Roberto Rivera‐Luna Breakdown of academic impact, for papers by Pamela J. Goodman Breakdown of academic impact, for papers by Jón Kristinsson Breakdown of academic impact, for papers by Ólafur Gísli Jónsson Breakdown of academic impact, for papers by Ólafur G. Jónsson
Rankless by CCL
2026